News
TEVJF
26.00
NaN%
--
Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade)
Seeking Alpha · 1d ago
Weekly Report: what happened at TEVJF last week (1124-1128)?
Weekly Report · 4d ago
CMS Slashes Prices Of 15 Major Drugs - Here's Why Pharma Valuations Won't Suffer
Seeking Alpha · 11/26 21:58
Weekly Report: what happened at TEVJF last week (1117-1121)?
Weekly Report · 11/24 09:30
Weekly Report: what happened at TEVJF last week (1110-1114)?
Weekly Report · 11/17 09:31
Generics Stalwart Teva Has Turned A Corner In Its Specialty Medicines Business
Seeking Alpha · 11/14 15:38
Weekly Report: what happened at TEVJF last week (1103-1107)?
Weekly Report · 11/10 09:30
Teva outlines path to $2.5B AUSTEDO revenue in 2027 as innovative portfolio grows 33%
Seeking Alpha · 11/05 18:02
Earnings Snapshot: Teva Pharmaceutical Industries tops Q3 estimates; updates FY outlook above forecast
Seeking Alpha · 11/05 13:32
Weekly Report: what happened at TEVJF last week (1027-1031)?
Weekly Report · 11/03 09:29
AbbVie: Why Q3 Confirms Its Immunology Dominance
Seeking Alpha · 10/31 14:39
Merck: Wall Street Surprised By Q3 Strength, Keytruda Sales Surge
Seeking Alpha · 10/30 13:20
Weekly Report: what happened at TEVJF last week (1020-1024)?
Weekly Report · 10/27 09:31
Weekly Report: what happened at TEVJF last week (1013-1017)?
Weekly Report · 10/20 09:30
Teva Vs. Viatris: Who Will Dominate In President Trump's America?
Seeking Alpha · 10/17 16:18
Johnson & Johnson Q3 Earnings Surprise, Icotrokinra Shines Again
Seeking Alpha · 10/14 12:58
Weekly Report: what happened at TEVJF last week (1006-1010)?
Weekly Report · 10/13 09:30
Undercovered Dozen: Petrobras, Richtech Robotics, Enbridge And More
Seeking Alpha · 10/10 13:35
East 72 Dynasty Trust Q3 2025 Quarterly Report
Seeking Alpha · 10/07 09:05
Teva Pharmaceutical: Turnaround Driven By Huge Pipeline Upside
Seeking Alpha · 10/07 08:07
More
Webull provides a variety of real-time TEVJF stock news. You can receive the latest news about Teva Pharmaceutical Industries through multiple platforms. This information may help you make smarter investment decisions.
About TEVJF
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.